Open access
Sep 2026
Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization.
Findings support BP lowering, particularly renin-angiotensin system inhibition, as a potential preventive strategy warranting dedicated randomized trials.
Yifan Hu, K. Smith-Byrne, Z. Bidel et al.
· HYPERTENSION · 0 citations